- Home
- OBIO vs MPA Comparison
OBIO vs MPA Comparison
Compare OBIO & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- MPA
- Stock Information
- Founded
- OBIO 2017
- MPA 1992
- Country
- OBIO United States
- MPA United States
- Employees
- OBIO N/A
- MPA N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- MPA Finance Companies
- Sector
- OBIO Health Care
- MPA Finance
- Exchange
- OBIO Nasdaq
- MPA Nasdaq
- Market Cap
- OBIO 151.3M
- MPA 139.0M
- IPO Year
- OBIO N/A
- MPA N/A
- Fundamental
- Price
- OBIO $2.89
- MPA $10.80
- Analyst Decision
- OBIO Strong Buy
- MPA
- Analyst Count
- OBIO 5
- MPA 0
- Target Price
- OBIO $14.20
- MPA N/A
- AVG Volume (30 Days)
- OBIO 193.1K
- MPA 25.2K
- Earning Date
- OBIO 05-12-2025
- MPA 01-01-0001
- Dividend Yield
- OBIO N/A
- MPA 3.83%
- EPS Growth
- OBIO N/A
- MPA N/A
- EPS
- OBIO N/A
- MPA N/A
- Revenue
- OBIO $2,886,000.00
- MPA N/A
- Revenue This Year
- OBIO $21.38
- MPA N/A
- Revenue Next Year
- OBIO $31.89
- MPA N/A
- P/E Ratio
- OBIO N/A
- MPA N/A
- Revenue Growth
- OBIO 30.23
- MPA N/A
- 52 Week Low
- OBIO $2.37
- MPA $9.87
- 52 Week High
- OBIO $8.87
- MPA $12.21
- Technical
- Relative Strength Index (RSI)
- OBIO 48.11
- MPA 46.40
- Support Level
- OBIO $2.76
- MPA $10.76
- Resistance Level
- OBIO $3.02
- MPA $11.23
- Average True Range (ATR)
- OBIO 0.18
- MPA 0.10
- MACD
- OBIO 0.03
- MPA -0.01
- Stochastic Oscillator
- OBIO 52.06
- MPA 36.50
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About MPA Blackrock MuniYield Pennsylvania Quality Fund
Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.